Tsukasa KITAHASHI,Shinji Mima,Takeshi Matsumoto,Takahiro Sekiguchi,Mikinaga Mori
申请号：
US16808004
公开号：
US20200197305A1
申请日:
2020.03.03
申请国别(地区):
US
年份:
2020
代理人:
摘要：
An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.
